183 related articles for article (PubMed ID: 27440072)
1. Release Characteristics In Vitro and In Vivo of In Situ Gels for a Novel Peptide Compared with Low-Molecular-Weight Hydrophilic Drug.
Zhang G; Hu J; Meng Q; Wang T; Yang X; Gao L; Quan D
Curr Drug Deliv; 2017; 14(1):47-53. PubMed ID: 27440072
[TBL] [Abstract][Full Text] [Related]
2. Sustained release of bee venom peptide from biodegradable thermosensitive PLGA-PEG-PLGA triblock copolymer-based hydrogels in vitro.
Qiao M; Chen D; Ma X; Hu H
Pharmazie; 2006 Mar; 61(3):199-202. PubMed ID: 16599259
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo release of albumin using a biodegradable MPEG-PCL diblock copolymer as an in situ gel-forming carrier.
Hyun H; Kim YH; Song IB; Lee JW; Kim MS; Khang G; Park K; Lee HB
Biomacromolecules; 2007 Apr; 8(4):1093-100. PubMed ID: 17326678
[TBL] [Abstract][Full Text] [Related]
4. Preparation and investigation of sustained drug delivery systems using an injectable, thermosensitive, in situ forming hydrogel composed of PLGA-PEG-PLGA.
Khodaverdi E; Tekie FS; Mohajeri SA; Ganji F; Zohuri G; Hadizadeh F
AAPS PharmSciTech; 2012 Jun; 13(2):590-600. PubMed ID: 22528547
[TBL] [Abstract][Full Text] [Related]
5. Drug release from a pH-sensitive multiblock co-polymer thermogel.
Garripelli VK; Namgung R; Kim WJ; Jo S
J Biomater Sci Polym Ed; 2012; 23(12):1505-19. PubMed ID: 21771392
[TBL] [Abstract][Full Text] [Related]
6. Structure-Performance Relationships of Temperature-Responsive PLGA-PEG-PLGA Gels for Sustained Release of Bone Morphogenetic Protein-2.
Santoveña A; Monzón C; Alvarez-Lorenzo C; Del Rosario C; Delgado A; Evora C; Concheiro A; Llabrés M; Fariña JB
J Pharm Sci; 2017 Nov; 106(11):3353-3362. PubMed ID: 28732712
[TBL] [Abstract][Full Text] [Related]
7. PLGA-PEG-PLGA tri-block copolymers as in situ gel-forming peptide delivery system: effect of formulation properties on peptide release.
Ghahremankhani AA; Dorkoosh F; Dinarvand R
Pharm Dev Technol; 2008; 13(1):49-55. PubMed ID: 18300099
[TBL] [Abstract][Full Text] [Related]
8. Studies on in vitro availability, degradation, and thermal properties of naltrexone-loaded biodegradable microspheres.
Akala EO; Wiriyacoonkasem P; Pan G
Drug Dev Ind Pharm; 2011 Jun; 37(6):673-84. PubMed ID: 21449706
[TBL] [Abstract][Full Text] [Related]
9. Morphology of nanostructures and their long-acting properties in vivo for a novel synthetic peptide of gonadotropin-releasing hormone antagonist.
Zhang G; Li J; Gao L; Wang T; Quan D
J Pharm Pharmacol; 2014 Aug; 66(8):1077-81. PubMed ID: 24579973
[TBL] [Abstract][Full Text] [Related]
10. Characterization of gelation process and drug release profile of thermosensitive liquid lecithin/poloxamer 407 based gels as carriers for percutaneous delivery of ibuprofen.
Djekic L; Krajisnik D; Martinovic M; Djordjevic D; Primorac M
Int J Pharm; 2015 Jul; 490(1-2):180-9. PubMed ID: 26002567
[TBL] [Abstract][Full Text] [Related]
11. Oil-based formulation as a sustained-released injection for a novel synthetic peptide.
Zhang G; Li J; Wang T; Gao L; Quan D
Curr Pharm Biotechnol; 2015; 16(2):187-93. PubMed ID: 25391244
[TBL] [Abstract][Full Text] [Related]
12. Release behavior and intra-articular biocompatibility of celecoxib-loaded acetyl-capped PCLA-PEG-PCLA thermogels.
Petit A; Sandker M; Müller B; Meyboom R; van Midwoud P; Bruin P; Redout EM; Versluijs-Helder M; van der Lest CH; Buwalda SJ; de Leede LG; Vermonden T; Kok RJ; Weinans H; Hennink WE
Biomaterials; 2014 Sep; 35(27):7919-28. PubMed ID: 24952978
[TBL] [Abstract][Full Text] [Related]
13. Injectable thermosensitive PLGA-PEG-PLGA triblock copolymers-based hydrogels as carriers for interleukin-2.
Qiao M; Chen D; Hao T; Zhao X; Hu H; Ma X
Pharmazie; 2008 Jan; 63(1):27-30. PubMed ID: 18271299
[TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson's disease.
Jiang Y; Zhang X; Mu H; Hua H; Duan D; Yan X; Wang Y; Meng Q; Lu X; Wang A; Liu W; Li Y; Sun K
Drug Deliv; 2018 Nov; 25(1):143-152. PubMed ID: 29275639
[TBL] [Abstract][Full Text] [Related]
15. Novel in situ gelling ocular films for the opioid growth factor-receptor antagonist-naltrexone hydrochloride: fabrication, mechanical properties, mucoadhesion, tolerability and stability studies.
Abdelkader H; Pierscionek B; Alany RG
Int J Pharm; 2014 Dec; 477(1-2):631-42. PubMed ID: 25445974
[TBL] [Abstract][Full Text] [Related]
16. Effect of Polyethylene Glycol on Properties and Drug Encapsulation-Release Performance of Biodegradable/Cytocompatible Agarose-Polyethylene Glycol-Polycaprolactone Amphiphilic Co-Network Gels.
Chandel AK; Kumar CU; Jewrajka SK
ACS Appl Mater Interfaces; 2016 Feb; 8(5):3182-92. PubMed ID: 26760672
[TBL] [Abstract][Full Text] [Related]
17. A long-acting formulation of a polypeptide drug exenatide in treatment of diabetes using an injectable block copolymer hydrogel.
Li K; Yu L; Liu X; Chen C; Chen Q; Ding J
Biomaterials; 2013 Apr; 34(11):2834-42. PubMed ID: 23352120
[TBL] [Abstract][Full Text] [Related]
18. Thermosensitive Pluronic hydrogel: prolonged injectable formulation for drug abuse.
Derakhshandeh K; Fashi M; Seifoleslami S
Drug Des Devel Ther; 2010 Sep; 4():255-62. PubMed ID: 20957216
[TBL] [Abstract][Full Text] [Related]
19. Oral liquid in situ gelling methylcellulose/alginate formulations for sustained drug delivery to dysphagic patients.
Shimoyama T; Itoh K; Kobayashi M; Miyazaki S; D'Emanuele A; Attwood D
Drug Dev Ind Pharm; 2012 Aug; 38(8):952-60. PubMed ID: 22283456
[TBL] [Abstract][Full Text] [Related]
20. Multivesicular liposome (MVL) sustained delivery of a novel synthetic cationic GnRH antagonist for prostate cancer treatment.
Wang T; Gao L; Quan D
J Pharm Pharmacol; 2011 Jul; 63(7):904-10. PubMed ID: 21635255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
